Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Wyllie

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Trends in Parasitology|April 30, 2014
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospectsStephen Patterson, Susan Wyllie
Biochemical Pharmacology|December 2, 2005
Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukaemia monocyte cell lineSusan Wyllie, Alan H Fairlamb
Acta Tropica|February 9, 2006
Refinement of techniques for the propagation of Leishmania donovani in hamstersSusan Wyllie, Alan H Fairlamb
Seminars in Cell & Developmental Biology|February 12, 2011
Methylglyoxal metabolism in trypanosomes and leishmaniaSusan Wyllie, Alan H Fairlamb
STAR Protocols|September 1, 2021
Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compoundsVictoriano Corpas-Lopez, Susan Wyllie
Frontiers in Drug Discovery|August 21, 2023
The critical role of mode of action studies in kinetoplastid drug discoveryAlan H Fairlamb, Susan Wyllie
Antimicrobial Agents and Chemotherapy|December 5, 2012
Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activationSusan Wyllie, Stephen Patterson, Alan H Fairlamb
The Journal of Biological Chemistry|August 24, 2004
Leishmania major elongation factor 1B complex has trypanothione S-transferase and peroxidase activityTim J Vickers, Susan Wyllie, Alan H Fairlamb
The Journal of Biological Chemistry|July 15, 2004
Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovaniSusan Wyllie, Mark L Cunningham, Alan H Fairlamb
Antimicrobial Agents and Chemotherapy|January 11, 2017
Snapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host CellsMarkela Koniordou, Stephen Patterson, Susan Wyllie, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Trends in Parasitology|April 30, 2014
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospectsStephen Patterson, Susan Wyllie
Biochemical Pharmacology|December 2, 2005
Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukaemia monocyte cell lineSusan Wyllie, Alan H Fairlamb
Acta Tropica|February 9, 2006
Refinement of techniques for the propagation of Leishmania donovani in hamstersSusan Wyllie, Alan H Fairlamb
Seminars in Cell & Developmental Biology|February 12, 2011
Methylglyoxal metabolism in trypanosomes and leishmaniaSusan Wyllie, Alan H Fairlamb
STAR Protocols|September 1, 2021
Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compoundsVictoriano Corpas-Lopez, Susan Wyllie
Frontiers in Drug Discovery|August 21, 2023
The critical role of mode of action studies in kinetoplastid drug discoveryAlan H Fairlamb, Susan Wyllie
Antimicrobial Agents and Chemotherapy|December 5, 2012
Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activationSusan Wyllie, Stephen Patterson, Alan H Fairlamb
The Journal of Biological Chemistry|August 24, 2004
Leishmania major elongation factor 1B complex has trypanothione S-transferase and peroxidase activityTim J Vickers, Susan Wyllie, Alan H Fairlamb
The Journal of Biological Chemistry|July 15, 2004
Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovaniSusan Wyllie, Mark L Cunningham, Alan H Fairlamb
Antimicrobial Agents and Chemotherapy|January 11, 2017
Snapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host CellsMarkela Koniordou, Stephen Patterson, Susan Wyllie, et al.
Pageof 10